Mankind Pharma Share Price
₹2,805.20 -85.85 (-2.97%)
21 Dec, 2024 18:04
Start SIP in MANKIND
Start SIPPerformance
- Low
- ₹2,755
- High
- ₹2,908
- 52 Week Low
- ₹1,851
- 52 Week High
- ₹2,923
- Open Price₹2,908
- Previous Close₹2,891
- Volume671,820
Investment Returns
- Over 1 Month + 8.97%
- Over 3 Month + 10.63%
- Over 6 Month + 27.74%
- Over 1 Year + 48.98%
Smart Investing Starts Here Start SIP with Mankind Pharma for Steady Growth!
Mankind Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 53.1
- PEG Ratio
- 1.5
- Market Cap Cr
- 112,394
- P/B Ratio
- 11.7
- Average True Range
- 101.48
- EPS
- 52.79
- Dividend Yield
- 0
- MACD Signal
- 24.32
- RSI
- 61.57
- MFI
- 80.4
Mankind Pharma Financials
Mankind Pharma Technicals
EMA & SMA
Current Price
₹2,805.20
-85.85
(-2.97%)
- Bullish Moving Average 16
- Bearish Moving Average 0
- 20 Day
- ₹2,679.19
- 50 Day
- ₹2,619.00
- 100 Day
- ₹2,525.42
- 200 Day
- ₹2,368.14
Resistance and Support
2822.73
- R3 3,043.47
- R2 2,975.73
- R1 2,890.47
- S1 2,737.47
- S2 2,669.73
- S3 2,584.47
Mankind Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-05 | Quarterly Results | |
2024-07-31 | Quarterly Results | |
2024-05-15 | Audited Results & Others | To evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
2024-01-31 | Quarterly Results | |
2023-10-31 | Quarterly Results |
Mankind Pharma F&O
About Mankind Pharma
- NSE Symbol
- MANKIND
- BSE Symbol
- 543904
- ISIN
- INE634S01028
Similar Stocks to Mankind Pharma
Mankind Pharma FAQs
Mankind Pharma share price is ₹2,805 As on 21 December, 2024 | 17:50
The Market Cap of Mankind Pharma is ₹112393.7 Cr As on 21 December, 2024 | 17:50
The P/E ratio of Mankind Pharma is 53.1 As on 21 December, 2024 | 17:50
The PB ratio of Mankind Pharma is 11.7 As on 21 December, 2024 | 17:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.